Pulmonary hypersensitivity reaction induced by efavirenz

Area of Science:

• Pharmacology
• Immunology
• Infectious Diseases

Background:

• Antiretroviral therapy is crucial for managing Human Immunodeficiency Virus (HIV) infection.
• Adverse drug reactions (ADRs), including skin manifestations like maculopapular rash, are common complications of antiretroviral drugs.
• Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are frequently associated with drug-induced exanthema, often necessitating treatment cessation.

Observation:

• A case of a severe pulmonary hypersensitivity reaction in an HIV-infected patient is presented.
• The reaction was attributed to efavirenz, a commonly used NNRTI.
• Pulmonary involvement represents a serious and less common manifestation of drug hypersensitivity.

Findings:

• Efavirenz-induced hypersensitivity can manifest with severe systemic symptoms, including pulmonary involvement.
• Prompt recognition and discontinuation of the offending agent are critical for managing such reactions.
• This case underscores the importance of monitoring for severe ADRs beyond cutaneous manifestations.

Implications:

• Clinicians should maintain a high index of suspicion for severe hypersensitivity reactions to efavirenz and other NNRTIs in HIV patients.
• Understanding the spectrum of efavirenz-induced ADRs is vital for optimizing HIV treatment strategies.
• Further research into predicting and preventing severe hypersensitivity reactions could improve patient outcomes and adherence to antiretroviral therapy.